Development of a surface plasmon resonance-based immunosensor for the rapid detection of cardiac troponin I

The concentration of cardiac troponin I (cTnI) in blood is an important marker for heart muscle cell damage. A surface plasmon resonance (SPR)-based immunosensor was devised for the rapid and specific detection of cTnI. It was constructed by crosslinking a monoclonal antibody P-II-13, which was generated against a loop region (aa 84–94) of cTnI protein as an epitope peptide, onto a chemically modified thin gold film. The performance of the sensor was examined with respect to the SPR signal intensity versus cTnI concentration. The signal intensity was directly correlated with the cTnI concentration in the range of 0–160 μg/l. The sensor signal was saturated when the concentration of cTnI approached 660 μg/l with the SPR intensity of 172 RU. The lower detection limit of the sensor was 68 ng/l cTnI, which was comparable to ELISA-based commercial cTnI detection systems.

[1]  S. Kim,et al.  Antibody-based surface plasmon resonance detection of intact viral pathogen. , 2006, Biotechnology and bioengineering.

[2]  A. Jaffe,et al.  Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. , 1994, The New England journal of medicine.

[3]  Yuichiro Maéda,et al.  Structure of the core domain of human cardiac troponin in the Ca2+-saturated form , 2003, Nature.

[4]  K. Johnston,et al.  Simultaneous determination of refractive index and absorbance spectra of chemical samples using surface plasmon resonance , 1995 .

[5]  A. Jaffe,et al.  It's time for a change to a troponin standard. , 2000, Circulation.

[6]  Shalini Gupta,et al.  An improved protocol for coupling synthetic peptides to carrier proteins for antibody production using DMF to solubilize peptides. , 2007, Journal of biomolecular techniques : JBT.

[7]  J. Tate Troponin revisited 2008: assay performance , 2008, Clinical chemistry and laboratory medicine.

[8]  B. Liedberg,et al.  Principles of biosensing with an extended coupling matrix and surface plasmon resonance , 1993 .

[9]  Y. Shirshov,et al.  Detection of plant viruses using a surface plasmon resonance via complexing with specific antibodies. , 2004, Journal of virological methods.

[10]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[11]  Se Young Oh,et al.  Electrochemical detection of cardiac troponin I using a microchip with the surface-functionalized poly(dimethylsiloxane) channel. , 2007, Biosensors & bioelectronics.

[12]  J. Potter,et al.  Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. , 1987, Annual review of biophysics and biophysical chemistry.

[13]  Min-Gon Kim,et al.  An application of protein microarray in the screening of monoclonal antibodies against the oyster mushroom spherical virus. , 2008, Analytical biochemistry.

[14]  K. Pulkki,et al.  Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. , 1997, Clinical chemistry.

[15]  K. Thygesen,et al.  Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .

[16]  Jack H. Ladenson,et al.  Cardiac Troponin I A Marker With High Specificity for Cardiac Injury , 1993, Circulation.

[17]  R. O'Kennedy,et al.  Cardiac biomarkers and the case for point-of-care testing. , 2009, Clinical biochemistry.

[18]  Robert H Christenson,et al.  Cardiac point of care testing: a focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms. , 2009, Clinical biochemistry.

[19]  R. Mellanby,et al.  Cardiac troponin I: evaluation I of a biomarker for the diagnosis of heart disease in the dog. , 2005, The Journal of small animal practice.

[20]  B. Lindahl,et al.  The antibody configurations of cardiac troponin I assays may determine their clinical performance. , 2006, Clinical chemistry.

[21]  S. Akhtar Biomarkers and perioperative myocardial infarction , 2003 .

[22]  Min-Gon Kim,et al.  Detection of the mycovirus OMSV in the edible mushroom, Pleurotus ostreatus, using an SPR biosensor chip. , 2008, Journal of virological methods.

[23]  J. Homola Present and future of surface plasmon resonance biosensors , 2003, Analytical and bioanalytical chemistry.